Connect Biopharma Holdings Ltd Liquidation Value
CNTB
Other
Cash & Equivalents
$38.34M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $38.34M
Total Obligations: -$14.30M
$24.04M
Per share: $0.43
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $38.34M
AR: $13,000
Total Obligations: -$14.30M
$24.05M
Per share: $0.43
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $38.34M
AR: $13,000
Inventory: $0
Total Obligations: -$14.30M
$24.05M
Per share: $0.43
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $24.04M | $0.43 |
| Liquid Liquidation Value | $24.05M | $0.43 |
| Operating Liquidation Value | $24.05M | $0.43 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $38.34M |
| Accounts Receivable | $13,000 |
| Inventory | N/A |
| Current Liabilities | $13.61M |
| Long-term Debt | N/A |
| Op. Lease Liability | $690,000 |
| Finance Lease | N/A |
| Shares Outstanding | 56.4M |
Explore all 166 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $38.34M | $13,000 | N/A | $1.96M | $13.61M | N/A | $690,000 | N/A |
| 2025-09-30 | $37.84M | $17,000 | N/A | $1.99M | $11.43M | N/A | $781,000 | N/A |
| 2025-06-30 | $40.63M | $0 | N/A | $2.29M | $10.74M | N/A | $870,000 | N/A |
| 2025-03-31 | $47.71M | $8,000 | N/A | $817,000 | $8.56M | N/A | $940,000 | N/A |
| 2024-12-31 | $78.23M | $789,000 | N/A | $342,000 | $8.46M | N/A | $178,000 | N/A |
| 2024-09-30 | $97.19M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-06-30 | $109.84M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-03-31 | $114.10M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes